Dissecting Fusiform Aneurysm: Definition and Treatment
What is a Dissecting Fusiform Aneurysm?
A dissecting fusiform aneurysm is an abnormal focal dilation of a cerebral artery characterized by circumferential vessel wall involvement without a definable neck, often resulting from arterial wall dissection with intramural hematoma formation. 1
- Fusiform aneurysms lack the typical saccular shape and instead show diffuse, spindle-shaped arterial dilation involving the entire vessel circumference without separate inflow and outflow points 1
- Dissecting aneurysms occur when blood penetrates the arterial wall layers, creating intramural or intraluminal thrombosis, often with an intimal flap visible on imaging 1, 2
- These lesions arise from traumatic, infectious, or congenital causes in children, while atherosclerosis is the predominant cause in adults 1
- MRI findings distinguish dissecting from fusiform aneurysms: dissecting aneurysms show intimal flaps, double lumens, intramural hematoma, or hematoma adjacent to the parent artery, while pure fusiform aneurysms show only signal-void dilation 2
How Dissecting Fusiform Aneurysms are Fixed
Medical Management (First-Line for Uncomplicated Cases)
Aggressive blood pressure and heart rate control forms the foundation of treatment for uncomplicated dissecting fusiform aneurysms, particularly in the posterior circulation. 3
- Target systolic blood pressure 100-120 mmHg and heart rate ≤60 beats per minute to reduce shear stress on the arterial wall 3
- Administer intravenous beta-blockers as first-line therapy (propranolol, esmolol, or labetalol) 3
- Add vasodilators like sodium nitroprusside only after beta-blockade is established—never use vasodilators alone as they cause reflex tachycardia and increase aortic wall stress 3
- Transition to oral beta-blockers after 24 hours of hemodynamic stability, targeting long-term blood pressure <135/80 mmHg 3
Surgical Treatment Indications
Surgical or endovascular intervention is required for symptomatic aneurysms, those showing growth, or when complications develop including persistent pain, rapid expansion, rupture, or ischemic symptoms. 1
Microsurgical Options:
- Parent vessel occlusion (trapping) with or without bypass is the most definitive treatment when the vessel can be sacrificed 4, 5
- Bypass procedures are necessary when the aneurysm involves arteries supplying critical brain tissue:
- Wada testing should be performed preoperatively to identify vascular territories with greatest risk of neurological deficit and determine revascularization necessity 5
- Use cerebral protectors and mild hypothermia during microsurgical procedures 5
Endovascular Options:
- Flow diversion has emerged as the primary endovascular treatment, covering the entry tear and redirecting blood flow to promote thrombosis and healing 3, 6
- Stent-assisted coiling may be attempted in select cases, though the lack of a true neck makes this challenging 6
- Balloon fenestration can treat dynamic obstruction of branch arteries 1
- Endovascular treatment should be followed by DSA at 6 months, then annual MRA 1
Location-Specific Considerations
Posterior circulation dissecting fusiform aneurysms carry particularly high surgical risk and require more frequent monitoring than anterior circulation lesions. 1
- Vertebrobasilar aneurysms are intimately associated with brainstem perforators, increasing surgical complexity 1
- More frequent follow-up is mandatory for fusiform and dissecting aneurysms compared to saccular aneurysms 1
- Unruptured posterior circulation dissecting/fusiform aneurysms have considerable rupture rates during follow-up, with growth associated with morbidity even without rupture 7
Follow-Up Protocol
Lifelong surveillance with decreasing frequency is essential, as these aneurysms can undergo delayed recurrence through recanalization after thrombosis. 1
- Initial follow-up: MRA or DSA at 6 months 1
- Subsequent imaging: MRA at 1,2, and 5 years, then every 5 years for life 1
- Use non-contrast-enhanced MRA for long-term follow-up to avoid gadolinium accumulation 1
- DSA is preferred over MRA for initial post-treatment assessment at 6 months for endovascularly treated aneurysms 1
- Monitor for de novo aneurysm formation, particularly in patients with underlying vasculopathy 1
High-Risk Features Requiring Aggressive Treatment
Aneurysms with the following characteristics are classified as "complex" and warrant closer surveillance or prophylactic treatment: 1
- Giant size (>25 mm) 1
- Presence of daughter sacs 1
- Fusiform/dissecting/non-saccular morphology 1
- Arteries supplying normal brain arising from the aneurysm dome or neck 1
- Initial symptomatic presentation, diabetes, coronary disease, or large baseline diameter—all associated with growth and rupture risk 7
Common Pitfalls
- Never use vasodilators without prior beta-blockade as this increases wall stress through reflex tachycardia 3
- Avoid dihydropyridine calcium channel blockers without beta-blockers for the same reason 3
- Repeated angiography is essential when angiospasm makes differentiation between dissecting and fusiform aneurysms difficult 2
- Thrombosis can induce accelerated fibrinolysis leading to recanalization, necessitating vigilant lifelong follow-up 1
- Infectious dissecting aneurysms require frequent imaging to assess antibiotic effectiveness and detect early recurrence 1